title: Factors affecting topotecan sensitivity in human leukemia samples.
authors.affiliation: Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA. Kaufmann.Scott@Mayo.edu
authors.forename: S H
authors.initials: SH
authors.lastname: Kaufmann
authors.forename: S D
authors.initials: SD
authors.lastname: Gore
authors.forename: L
authors.initials: L
authors.lastname: Letendre
authors.forename: P A
authors.initials: PA
authors.lastname: Svingen
authors.forename: T
authors.initials: T
authors.lastname: Kottke
authors.forename: C A
authors.initials: CA
authors.lastname: Buckwalter
authors.forename: R J
authors.initials: RJ
authors.lastname: Jones
authors.forename: L B
authors.initials: LB
authors.lastname: Grochow
authors.forename: P J
authors.initials: PJ
authors.lastname: Burke
authors.forename: R C
authors.initials: RC
authors.lastname: Donehower
authors.forename: E K
authors.initials: EK
authors.lastname: Rowinsky
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002454:Cell Differentiation; D017321:Clinical Trials, Phase I as Topic; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D002166:Camptothecin